The presence of MOG Abs in MS was analyzed in 23/26 studies and the overall sensitivity for MS was 5.1% (95% CI 4.2–6.1) and thus 5.1% (range 0–46.7%) of all MS patients were seropositive for MOG Abs. Here, MOG is linked to myeloid sarcoma.